Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 161 | CRSP | CRISPR THERAPEUTICS AG | Healthcare | 23,351.0 | $1.3M | 0.30% | +8K | +56.8% | $54.54 | -5.0% |
| 162 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 15,605.0 | $1.3M | 0.30% | +4K | +29.6% | $81.51 | -13.3% |
| 163 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 22,346.0 | $1.3M | 0.30% | -2K | -7.8% | $56.81 | +10.0% |
| 164 | INSM | INSMED INC | Healthcare | 11,884.0 | $1.3M | 0.29% | +8K | +177.5% | $106.62 | +12.5% |
| 165 | OMER | OMEROS CORP | Healthcare | 133,129.0 | $1.3M | 0.29% | +106K | +395.6% | $9.51 | +80.5% |
| 166 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 33,736.0 | $1.3M | 0.29% | +17K | +101.8% | $37.42 | +127.0% |
| 167 | PTCT | PTC THERAPEUTICS INC | Healthcare | 15,476.0 | $1.3M | 0.29% | +4K | +38.7% | $81.57 | -19.5% |
| 168 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 15,870.0 | $1.3M | 0.29% | +5K | +51.9% | $79.29 | -40.4% |
| 169 | BIIB | BIOGEN INC | Healthcare | 5,813.0 | $1.3M | 0.29% | +965.0 | +19.9% | $216.06 | +0.1% |
| 170 | — | BEONE MEDICINES LTD | — | 4,397.0 | $1.3M | 0.29% | +2K | +66.2% | $284.97 | — |
| 171 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 47,698.0 | $1.3M | 0.29% | +19K | +64.0% | $26.22 | -10.3% |
| 172 | AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | 73,507.0 | $1.2M | 0.29% | +20K | +38.0% | $16.97 | -4.9% |
| 173 | NVAX | NOVAVAX INC | Healthcare | 130,955.0 | $1.2M | 0.29% | +2K | +1.9% | $9.42 | -2.0% |
| 174 | HRMY | HARMONY BIOSCIENCES HLDGS IN | Healthcare | 33,746.0 | $1.2M | 0.29% | +13K | +61.9% | $36.41 | +15.8% |
| 175 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 7,279.0 | $1.2M | 0.29% | +2K | +31.8% | $168.53 | -11.0% |
| 176 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 112,139.0 | $1.2M | 0.28% | +54K | +93.4% | $10.85 | -24.8% |
| 177 | BNTX | BIONTECH SE | Healthcare | 12,844.0 | $1.2M | 0.28% | +4K | +44.2% | $93.05 | +3.9% |
| 178 | HRZN | HORIZON TECHNOLOGY FIN CORP | Financial Services | 252,455.0 | $1.2M | 0.28% | +108K | +75.3% | $4.73 | -0.8% |
| 179 | EXEL | EXELIXIS INC | Healthcare | 21,887.0 | $1.2M | 0.28% | +1K | +6.0% | $54.41 | +4.6% |
| 180 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 20,784.0 | $1.2M | 0.28% | +5K | +31.2% | $57.22 | +12.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.2%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%